VAC_85_2024 - RESEARCHER ASSISTANT

Temporary, Full-time · IJC Can Ruti

Your mission

The Josep Carreras Leukemia Research Institute (IJC) is a comprehensive cancer research center dedicated to researching and promoting innovation in the epidemiological, preventive, clinical, translational and basic aspects of leukemia and other hematological malignancies, with the objective end of finding a cure for these diseases. It was created in 2010, and since then, it has experienced exponential growth.

The IJC is also part of the network of Research Centers of Excellence of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) In addition, the IJC is one of the centers integrated into the accreditation of the Germans Trias i Pujol Research Institute (IGTP) as an Accredited Health Research Institute (IIS) by the Health Institute Charles III (ISCIII).

The IJC main headquarters is located within the Can Ruti Biomedical Campus, together with other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six headquarters integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.

The contract is subsidized by the project de I+D+i PID2022-140376OB-I00 funded by the Ministry of Science and Innovation, AEI/10.13039/501100011033. Co-financed by the European Regional Development Fund. FEDER A Way of Making Europe.

RESEARCH DESCRIPTION

Epigenetic Control of Haematopoiesis Group is working to uncover the molecular mechanisms governing blood cell fate decisions, with a special interest in those leading to the onset of clonal haematopoiesis and myeloid malignancies (AML, MDS, CMML…) during ageing. To address this goal, they are combining transcriptome (by RNA-seq) and epigenomic profiling (by WG(ox)BS-seq, ATAC-seq and ChIP-seq for histone marks) in human and mouse primary blood samples with in-depth molecular studies (by CRISPR/Cas9 (epi)genome editing) in unique cellular models of experimentally induced blood cell fate conversions.

Please also visit our group webpage: https://www.carrerasresearch.org/en/research/epigenetic-control-of-haematopoiesis

Your profile

WHAT WE NEED

We are seeking a highly motivated, talented researcher assistant to join our team and contribute to this exciting project.

General skills

A committed scientist with a competitive scientific record and experience in biology, biomedicine, or related disciplines.
A high level of motivation and interest in biomedical research.
Good communication skills.
Fluent in English

Technical skills

Degree in Biology or Biochemistry (or related field).
MSc in Cell Biology, hematology or related field.

Why us?

WHAT WE OFFER

Incorporation in a multinational and highly collaborative team.
An innovative and interdisciplinary research project.
Mixed basic and clinical research environment of the Josep Carreras Leukaemia Research Institute.
The stimulating environment of the Barcelona metropolitan area.
The contract is subsidized by the project de I+D+i PID2022-140376OB-I00, funded by the Ministry of Science and Innovation, AEI/10.13039/501100011033. Co-financed by the European Regional Development Fund. FEDER A Way of Making Europe.

How to apply?

Please submit your application by 20/11/2024

Apply for this job

About us

What makes us different?

The mission of the Josep Carreras Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of cancer, with a special emphasis on leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases.

The IJC’s vision is to be a world-class reference and excellent research multicampus that contributes to the improvement of results, and the cure of patients affected by leukemia and other malignant hemopathies, through innovation, sustainability, social responsibility, talent, and professional experience.

HR Excellence

In 2019, IJC was honored with the “Human Resources Excellence in Research Award” by the European Commission, recognizing the alignment of our human resources policies with the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers. The Human Resources Strategy for Researchers (HRS4R) guides research centers of excellence in implementing and upholding these standards within their policies, emphasizing training, professional development, and mobility opportunities.

The IJC’s commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and environment for their professional development.

The IJC is an equal opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics.

Apply for this job

We are looking forward to hearing from you!

Thank you for your interest in IJC. Please fill out the following short form.
Should you have difficulties with the upload of your data, please send an email to jobs.ijc@carrerasresearch.org